PT2878300T - Penso - Google Patents

Penso

Info

Publication number
PT2878300T
PT2878300T PT138231774T PT13823177T PT2878300T PT 2878300 T PT2878300 T PT 2878300T PT 138231774 T PT138231774 T PT 138231774T PT 13823177 T PT13823177 T PT 13823177T PT 2878300 T PT2878300 T PT 2878300T
Authority
PT
Portugal
Prior art keywords
patch
Prior art date
Application number
PT138231774T
Other languages
English (en)
Inventor
Sonobe Atsushi
Yasukochi Takashi
Takada Yasunori
Original Assignee
Hisamitsu Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hisamitsu Pharmaceutical Co filed Critical Hisamitsu Pharmaceutical Co
Publication of PT2878300T publication Critical patent/PT2878300T/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Inorganic Chemistry (AREA)
  • Hematology (AREA)
  • Anesthesiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medical Informatics (AREA)
  • Psychiatry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
PT138231774T 2012-07-26 2013-07-25 Penso PT2878300T (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2012165793 2012-07-26
JP2013078583 2013-04-04

Publications (1)

Publication Number Publication Date
PT2878300T true PT2878300T (pt) 2017-08-01

Family

ID=49997402

Family Applications (2)

Application Number Title Priority Date Filing Date
PT138231774T PT2878300T (pt) 2012-07-26 2013-07-25 Penso
PT138225032T PT2878299T (pt) 2012-07-26 2013-07-25 Emplastro adesivo

Family Applications After (1)

Application Number Title Priority Date Filing Date
PT138225032T PT2878299T (pt) 2012-07-26 2013-07-25 Emplastro adesivo

Country Status (10)

Country Link
US (5) US9511051B2 (pt)
EP (3) EP2878299B1 (pt)
JP (5) JP6005741B2 (pt)
KR (3) KR102013478B1 (pt)
CN (3) CN104487071B (pt)
ES (3) ES2681034T3 (pt)
PL (2) PL2878299T3 (pt)
PT (2) PT2878300T (pt)
TW (3) TWI592170B (pt)
WO (3) WO2014017595A1 (pt)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11123305B2 (en) * 2012-07-26 2021-09-21 Hisamitsu Pharmaceutical Co., Inc. Patch
PT2878300T (pt) * 2012-07-26 2017-08-01 Hisamitsu Pharmaceutical Co Penso
US20180360968A1 (en) * 2012-07-26 2018-12-20 Hisamitsu Pharmaceutical Co., Inc. Patch
US10493156B2 (en) 2012-07-26 2019-12-03 Hisamitsu Pharmaceutical Co., Inc. Patch and method for producing the same
JPWO2015072494A1 (ja) 2013-11-12 2017-03-16 扶桑薬品工業株式会社 新規二酢酸ナトリウム結晶及び該結晶を含有する固形透析用製剤
JP2016153391A (ja) * 2015-02-16 2016-08-25 日本合成化学工業株式会社 無水酢酸ナトリウム結晶
CN107847487B (zh) * 2015-07-27 2021-11-02 久光制药株式会社 含有阿塞那平的贴剂
KR102005201B1 (ko) * 2015-07-27 2019-07-29 히사미쓰 세이야꾸 가부시키가이샤 아세나핀 함유 첩부제의 제조 방법
MY196043A (en) * 2016-10-28 2023-03-09 Tomita Pharma Higher-Order Acetate Compound, and Solid Dialysis Agent Using Same
US20180193283A1 (en) * 2016-12-20 2018-07-12 Lts Lohmann Therapie-Systeme Ag Transdermal therapeutic system containing asenapine
MX2019007389A (es) * 2016-12-20 2019-08-16 Lts Lohmann Therapie Systeme Ag Sistema terapeutico transdermico que contiene asenapina y polisiloxano o poliisobutileno.
JP2020525545A (ja) * 2017-06-26 2020-08-27 エルテーエス ローマン テラピー−ジステーメ アーゲー アセナピンおよびシリコーンアクリルハイブリッドポリマーを含有する経皮治療システム
CA3101420A1 (en) * 2018-06-20 2019-12-26 Lts Lohmann Therapie-Systeme Ag Transdermal therapeutic system containing asenapine
US20210251914A1 (en) * 2018-06-20 2021-08-19 Lts Lohmann Therapie-Systeme Ag Transdermal therapeutic system containing asenapine
JP7274834B2 (ja) * 2018-08-10 2023-05-17 久光製薬株式会社 アセナピン含有貼付剤
EP3861998B1 (en) * 2018-10-01 2024-02-07 Hisamitsu Pharmaceutical Co., Inc. Asenapine-containing adhesive patch
EP3861999A4 (en) 2018-10-01 2022-06-22 Hisamitsu Pharmaceutical Co., Inc. ADHESIVE PAD CONTAINING ASENAPINE
JP2020141256A (ja) 2019-02-28 2020-09-03 ソニーセミコンダクタソリューションズ株式会社 復調回路、復調方法、送信装置
CN110123793A (zh) * 2019-06-03 2019-08-16 深圳市泛谷药业股份有限公司 一种阿塞那平或其盐的贴剂及其制备方法
US20210228496A1 (en) * 2020-01-24 2021-07-29 Hisamitsu Pharmaceutical Co., Inc. Method for reducing skin sensitization of an asenapine-containing patch
US20230034383A1 (en) * 2021-07-21 2023-02-02 Hisamitsu Pharmaceutical Co., Inc. Method for reducing skin sensitization of an asenapine-containing patch

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0747535B2 (ja) 1985-11-26 1995-05-24 日東電工株式会社 消炎鎮痛用貼付剤
JPH01207246A (ja) 1988-02-12 1989-08-21 Nissan Chem Ind Ltd 外用製剤用基剤組成物及び外用医薬組成物
DE69009540T2 (de) 1989-03-15 1994-09-29 Nitto Denko Corp Arzneimittel enthaltendes Heftpflaster.
JP2933944B2 (ja) * 1989-03-29 1999-08-16 日東電工株式会社 医療用貼付剤
JP2693212B2 (ja) * 1989-03-28 1997-12-24 日東電工株式会社 疾患治療用テープ製剤
TW411277B (en) * 1996-05-13 2000-11-11 Hisamitsu Pharmaceutical Co Percutaneous tape preparation containing fentanyl
JP3184474B2 (ja) 1997-03-10 2001-07-09 ニチバン株式会社 経皮吸収製剤
DE19814083C2 (de) 1998-03-30 2002-02-07 Lohmann Therapie Syst Lts Verfahren zur Herstellung von transdermalen therapeutischen Systemen unter Verwendung von basischen Alkalimetallsalzen zur Umwandlung von Wirkstoffsalzen in die freien Basen
JP4205778B2 (ja) * 1998-04-17 2009-01-07 久光製薬株式会社 貼付製剤
US6129929A (en) 1998-10-30 2000-10-10 Noven Pharmaceuticals, Inc. Patch applicator
DE60045153D1 (de) 1999-04-13 2010-12-09 Hisamitsu Pharmaceutical Co Zubereitungen zur perkutanen absorption
ES2286028T3 (es) * 1999-07-27 2007-12-01 Hisamitsu Pharmaceutical Co. Inc. Parches para uso externo.
US20040142024A1 (en) 1999-07-27 2004-07-22 Hisamitsu Pharmaceutical Co., Inc. Patch formulation for external use
US6586000B2 (en) * 1999-12-16 2003-07-01 Dermatrends, Inc. Hydroxide-releasing agents as skin permeation enhancers
US6966990B2 (en) * 2002-10-11 2005-11-22 Ferro Corporation Composite particles and method for preparing
JPWO2005115355A1 (ja) 2004-05-28 2008-03-27 久光製薬株式会社 貼付製剤
EP2216018B1 (en) 2004-10-21 2012-04-04 Durect Corporation Transdermal delivery systems
EP1710245B1 (en) * 2005-04-07 2007-08-22 N.V. Organon Crystal form of asenapine maleate
WO2007077741A1 (ja) * 2005-12-28 2007-07-12 Hisamitsu Pharmaceutical Co., Inc. 経皮吸収型製剤
JP5181320B2 (ja) 2006-10-18 2013-04-10 ニチバン株式会社 皮膚刺激の少ない経皮吸収型製剤
EP2255809B1 (en) 2008-02-27 2017-08-23 Hisamitsu Pharmaceutical Co., Inc. Medicated patch
JP5618822B2 (ja) * 2008-03-03 2014-11-05 久光製薬株式会社 経皮吸収製剤
JP5301190B2 (ja) * 2008-03-31 2013-09-25 積水メディカル株式会社 貼付剤
AU2008359725A1 (en) 2008-07-24 2010-01-28 Handa Pharmaceuticals, Llc Stabilized atypical antipsychotic formulation
WO2010119455A2 (en) 2009-04-15 2010-10-21 Sun Pharma Advanced Research Company Ltd. An injectable sustained release pharmaceutical composition
WO2010127674A1 (en) * 2009-05-06 2010-11-11 Sunin K/S Transdermal compositions of asenapine for the treatment of psychiatric disorders
EP2453870A2 (en) * 2009-06-24 2012-05-23 MSD Oss B.V. Injectable formulations containing asenapine and method of treatment using same
JP5654006B2 (ja) * 2010-04-28 2015-01-14 久光製薬株式会社 皮膚刺激抑制剤及び経皮吸収製剤
WO2012066565A2 (en) 2010-11-16 2012-05-24 Cadila Healthcare Limited Asenapine maleate amorphous and crystalline form and process for preparation thereof
PT2878300T (pt) * 2012-07-26 2017-08-01 Hisamitsu Pharmaceutical Co Penso

Also Published As

Publication number Publication date
PL2878300T3 (pl) 2017-10-31
TWI592170B (zh) 2017-07-21
CN104507472A (zh) 2015-04-08
WO2014017593A1 (ja) 2014-01-30
US20170035732A1 (en) 2017-02-09
CN104487072A (zh) 2015-04-01
WO2014017594A1 (ja) 2014-01-30
EP2878299B1 (en) 2018-05-16
TW201410270A (zh) 2014-03-16
TWI603748B (zh) 2017-11-01
CN104507472B (zh) 2016-10-05
CN104487071A (zh) 2015-04-01
EP2878300B1 (en) 2017-05-03
US9687474B2 (en) 2017-06-27
PL2878299T3 (pl) 2018-10-31
US20150231250A1 (en) 2015-08-20
US20170172981A1 (en) 2017-06-22
KR20150036477A (ko) 2015-04-07
JP6286011B2 (ja) 2018-02-28
KR102013478B1 (ko) 2019-08-22
KR20150036478A (ko) 2015-04-07
JP6272418B2 (ja) 2018-01-31
JPWO2014017593A1 (ja) 2016-07-11
PT2878299T (pt) 2018-07-06
CN104487072B (zh) 2017-08-04
EP2878299A4 (en) 2016-03-09
EP2878298B1 (en) 2017-05-03
WO2014017595A1 (ja) 2014-01-30
EP2878299A1 (en) 2015-06-03
EP2878298A1 (en) 2015-06-03
US20150202183A1 (en) 2015-07-23
EP2878298A4 (en) 2016-03-09
ES2633974T3 (es) 2017-09-26
JP2016199603A (ja) 2016-12-01
JPWO2014017595A1 (ja) 2016-07-11
CN104487071B (zh) 2017-06-13
EP2878300A4 (en) 2016-03-09
JPWO2014017594A1 (ja) 2016-07-11
US10080738B2 (en) 2018-09-25
KR102013477B1 (ko) 2019-08-22
JP2017025111A (ja) 2017-02-02
ES2632946T3 (es) 2017-09-18
US9511051B2 (en) 2016-12-06
ES2681034T3 (es) 2018-09-11
JP6067707B2 (ja) 2017-01-25
EP2878300A1 (en) 2015-06-03
US10022445B2 (en) 2018-07-17
KR20150036479A (ko) 2015-04-07
TW201410272A (zh) 2014-03-16
TW201410271A (zh) 2014-03-16
JP6005742B2 (ja) 2016-10-12
TWI594771B (zh) 2017-08-11
JP6005741B2 (ja) 2016-10-12
US20150164862A1 (en) 2015-06-18
KR102013476B1 (ko) 2019-08-22
US10583121B2 (en) 2020-03-10

Similar Documents

Publication Publication Date Title
PL2878300T3 (pl) Plaster
DK3327112T3 (en) Agse-deficient stamme
EP2754580A4 (en) DUMP TRUCK
SG11201404815YA (en) Transdermal patch
EP2935220A4 (en) PERI-carbinol
PL2859892T3 (pl) Plaster
HUE037454T2 (hu) Bõrtapasz
EP2812698A4 (en) TIME RESOLVED FREIGHT AND DOUBLE ACCEPTOR
EP2907515A4 (en) SKIN PATCH
PL2841457T3 (pl) Przeciwciało anty-ROBO4
EP2920157A4 (en) DI MACRO CYCLEN
EP2873363A4 (en) DIOPSIMETER
EP2881114A4 (en) ANTI-TRICHOPHYTIC ADHESIVE STAMP
GB2504561B (en) Patch antenna
EP2834250A4 (de) Lithiumsilikate
HK1212234A1 (en) Ropinirole-containing adhesive patch
HK1198419A1 (en) Transdermal patch
GB201213709D0 (en) Patch
GB201203767D0 (en) A patch
AU342207S (en) Jewelley setting
GB201202959D0 (en) Repair patch
GB201202887D0 (en) TV-audio
GB201202655D0 (en) Ecogaz
GB201202648D0 (en) Xstyler
GB201202382D0 (en) Flexfix